You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A medical genetics practice's lawsuit against a government insurance administrator points to continued uncertainty about reimbursement for NGS testing in Germany.
Good Start will serve as an in-network laboratory partner for a variety of genetic screening tests.
As president and CEO of the Rady Pediatric Genomics and Systems Medicine Institute, Kingsmore will be working toward adopting genomics to transform pediatric care.
The researchers increased the test's sensitivity for nucleotide variants from less than 96 percent to 99.5 percent and reduced the time to provisional results from 50 hours to 26 hours.
The companies are launching new clinical exome sequencing services called Exomax.
The software offers data processing and management capabilities that are designed to support more automated and efficient whole-exome sequencing-based testing.
The panels yielded a diagnosis for 43 percent of more than 2,300 patients, at a cost between $75 and $150 per panel.
The company recently launched a next-gen sequencing newborn screening panel, targeting 89 genes that have been linked to more than 60 metabolic conditions.
The privately-held German firm also plans to offer genetic tumor profiling and noninvasive prenatal testing.
The retrospective study, by researchers at Children's Mercy Kansas City, suggests the STAT-seq test has clinical utility in some patients.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.